Close | |
Figure 1: Histopathology showing (a) immunohistochemistry of glioblastoma, isocitrate dehydrogenase-wild-type immunonegativity for isocitrate dehydrogenase 1 (×200); nuclear immunopositivity for ATRX (×200); (b) immunohistochemistry of glioblastoma, isocitrate dehydrogenase-mutant cytoplasmic immunopositivity for isocitrate dehydrogenase 1 (×200) and loss of nuclear expression of ATRX (×200) |
|